Chinese Journal of Pharmaceuticals
|
2023, 54(6): 945-949
• Pharmaceutical Management & Information •
Introduction and Enlightenment on Communication Mechanism of FDA Review and Approval of Complex Generic Drugs
Full
Yangfan SHI, Xiaoling GONG, Jianzhou YAN, Rong SHAO
*
Affiliations
- Key Lab. of Drug Regulatory Innovation and Evaluation, NMPA, Research Institute of Drug Regulatory Sciences, China Pharmaceutical University, Nanjing 211198
Published: 2023-06-10
doi: 10.16522/j.cnki.cjph.2023.06.016
Outline
史扬帆, 龚小玲, 颜建周, 邵蓉.
FDA复杂仿制药审评审批沟通机制的简介与启示.
中国医药工业杂志,
2023
, 54
(6)
: 945
-949
.
DOI: 10.16522/j.cnki.cjph.2023.06.016
Yangfan SHI, Xiaoling GONG, Jianzhou YAN, Rong SHAO.
Introduction and Enlightenment on Communication Mechanism of FDA Review and Approval of Complex Generic Drugs[J].
Chinese Journal of Pharmaceuticals,
2023
, 54
(6)
: 945
-949
.
DOI: 10.16522/j.cnki.cjph.2023.06.016
Year 2023 volume 54 Issue 6
29
9
Cite this Article
BibTeX
Article Info
doi: 10.16522/j.cnki.cjph.2023.06.016
- Receive Date:2023-01-10
- Online Date:2026-11-19
- Published:2023-06-10